Sanfilippo Syndrome Market is Anticipated to Witness High Growth Owing to Promising Drug Pipeline
Sanfilippo syndrome, also known as mucopolysaccharidosis type III (MPS III), is a rare inherited genetic lysosomal storage disease characterized by deficiency in one of the four enzymes involved in breakdown and metabolism of heparan sulfate. This leads to buildup of heparan sulfate in the brain and other tissues. Clinical manifestations include progressive loss of cognitive abilities and motor...
0 Comments 0 Shares 18 Views 0 Reviews
Sponsored